HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G L Phillips Selected Research

Stem Cell Transplantation

11/2005What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.
11/2004Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.
4/2001Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.
12/2000Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease.
10/2000Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer.
2/2000Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G L Phillips Research Topics

Disease

3Leukemia
03/2008 - 10/2000
3Hematologic Neoplasms (Hematological Malignancy)
11/2005 - 08/2003
3Lymphoma (Lymphomas)
12/2004 - 12/2000
3Hodgkin Disease (Hodgkin's Disease)
11/2004 - 12/2000
3Neoplasms (Cancer)
07/2004 - 01/2000
3Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2000 - 01/2000
2Multiple Myeloma
01/2016 - 09/2000
2Breast Neoplasms (Breast Cancer)
04/2001 - 10/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2001 - 10/2000
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2000 - 01/2000
1Mucositis
01/2016
1Hemorrhage
11/2005
1Heart Failure
07/2004
1Cardiomyopathies (Cardiomyopathy)
07/2004
1Necrosis
07/2004
1Cardiotoxicity
07/2004
1Atrial Fibrillation
07/2004
1Disease Progression
07/2004
1Hemolytic Anemia
02/2000

Drug/Important Bio-Agent (IBA)

4Melphalan (Alkeran)FDA LinkGeneric
01/2016 - 04/2004
3Amifostine (Ethyol)FDA LinkGeneric
01/2016 - 04/2004
2VaccinesIBA
04/2001 - 10/2000
1Etoposide (VP 16)FDA LinkGeneric
12/2004
1Carmustine (FIVB)FDA Link
12/2004
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2004
1Monoclonal AntibodiesIBA
04/2001
1Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA
04/2001
1Complementary DNA (cDNA)IBA
04/2001
1Death-Associated Protein KinasesIBA
04/2001
1Biological ProductsIBA
10/2000
1Interleukin-3 Receptor alpha SubunitIBA
10/2000

Therapy/Procedure

6Stem Cell Transplantation
11/2005 - 02/2000
3Therapeutics
11/2005 - 09/2000
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2003 - 01/2000
2Homologous Transplantation
12/2000 - 01/2000
1Platelet Transfusion (Blood Platelet Transfusions)
03/2008
1BEAM regimen
12/2004
1Hematopoietic Stem Cell Transplantation
12/2004
1Combination Drug Therapy (Combination Chemotherapy)
12/2004
1Consolidation Chemotherapy
11/2004
1Autologous Transplantation
11/2004
1Drug Therapy (Chemotherapy)
04/2001
1Chemoradiotherapy
12/2000